For many people, GLP-1 medications are known simply as “weight-loss injections.” While weight reduction is certainly an important benefit, research over the last several years has revealed something much more remarkable. Scientists now recognize that GLP-1...
The short answer is generally no. If you already receive coverage for a GLP-1 medication such as Ozempic® through your Medicare Part D prescription drug plan for Type 2 diabetes, you generally cannot switch to the Medicare GLP-1 Bridge Program. The Bridge Program was...
A Review of the Science Behind Medicare’s New Approach to Obesity Treatment and Cardiovascular Disease Prevention Beginning in July 2026, the Centers for Medicare & Medicaid Services (CMS) launched the Medicare GLP-1 Bridge Program, a temporary demonstration...
Published by DPC Medical-Dodson Pain Consultants, PA For millions of Americans, managing obesity and weight-related health conditions has been challenging—not only because of the complexity of weight loss itself, but also because of the cost of newer prescription...
For many people, losing weight isn’t simply a matter of eating less and exercising more. Obesity is now recognized as a chronic medical condition influenced by genetics, hormones, metabolism, medications, stress, sleep, and lifestyle. Fortunately, advances in...
